Laddar populära aktier...
- Q2 was likely the trough - Small estimate revisions, good prospects for a better H2 - Poised for i...
Redeye remains confident on the case, despite the unexpected news of CEO Axel Berntsson leaving the ...
Redeye is surprised to hear that CEO Axel Berntsson is leaving the company to take on the role as CE...
Vaisala reports its Q2/24 results on Thursday 25th of July.
Ahead of its Q2 results on 6 August, we remain positive about NoHo's relative performance in a muted...
Redeye comments on W5 Solutions Q2-results which were weaker than estimated owing to a soft topline ...
Redeye updates on Evolution following its Q2-results which saw somewhat softer topline and profitabi...
Redeye is making some minor downward adjustments to our financial forecasts, following the Q2 report...
We keep our estimates intact ahead of CapMan’s Q2 report due on 8 August.
Redeye comments on Sivers’ announcement of a new CEO, which Redeye believes to be a good fit for the...
Consti’s Q2 results beat our estimates for both net sales and EBIT.
- 25% miss on adj EBIT - Lower on sales and weaker gross margin - Estimates likely down 5-8% on adj.
- We cut '24e sales and EBITDA by 2% and 21%, respectively - Headwinds for Aurdel likely to persist ...
Vitrolife delivered a surprising organic growth recovery with 4% organic growth and even if there wa...
Redeye thinks the Q2 report was strong in all aspects.